Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Lymphoid 2Plasma cell 1Classical hematology 1

Conditions

Leukemia 33Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma 19Myelodysplastic Syndromes 16Hodgkin Disease 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Leukemia, Myeloid, Acute 10Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Recurrence 6Myeloproliferative Disorders 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Neoplasms, Plasma Cell 4Lymphoma, T-Cell, Cutaneous 4Congenital Abnormalities 4Burkitt Lymphoma 4Anemia, Aplastic 4Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Brentuximab Vedotin 13fludarabine 8Cyclophosphamide 8Rituximab 6ruxolitinib 5fludarabine phosphate 5Melphalan 5Lenalidomide 5ponatinib 4Dexamethasone 4Busulfan 4Bortezomib 4nilotinib 3Whole-Body Irradiation 3Vincristine 3Prednisone 3Mycophenolic Acid 3Imatinib Mesylate 3Doxorubicin 3Bendamustine Hydrochloride 3Alemtuzumab 3vosaroxin 2pomalidomide 2Tacrolimus 2Sugars 2Stem Cell Transplantation 2Sirolimus 2Ondansetron 2Leukapheresis 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Hematologic Diseases × Alemtuzumab × Clear all
NCT01191749 2017-05-09

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

M.D. Anderson Cancer Center

Phase 2 Terminated
7 enrolled 6 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00582894 2011-04-22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

University of Oklahoma

Phase NA Completed
17 enrolled 9 charts
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡